BTG is proud to officially be a part of Boston Scientific BTG is a global healthcare company focused on Interventional Medicine. Our innovative medical technology helps physicians treat their patients through minimally invasive procedures. Today we have a growing portfolio of products that advance the treatment of cancer, vascular conditions and severe emphysema. Our Pharmaceuticals business provides products that help patients overexposed to certain medications or toxins. Our mission is to provide imaginative new ways to treat disease; making a real difference for patients, and a valuable contribution to healthcare. As medicine moves from major surgery to minor procedure, no company endeavours to do more to help doctors in their quest to see more, reach further and treat smarter. We understand their needs and equip them with tools and techniques that would have seemed like science fiction only a generation ago. We invest in clinical evidence that helps demonstrate the value of our treatments to patients, doctors, and healthcare systems. With relentless curiosity we’ll work with clinicians to find elegant new ways to extend our power over disease and transform patient care. There are no limits to where our ideas will take us.
Looking for a particular BTG plc employee's phone or email?
The BTG plc annual revenue was $14.7 billion in 2026.
Stephen Sy is the ceo of BTG plc.
199 people are employed at BTG plc.
BTG plc is based in Marlborough, Massachusetts.
The NAICS codes for BTG plc are [3254, 325, 541, 32541, 32, 5417, 54].
The SIC codes for BTG plc are [283, 28].